Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
VALCHLOR (MECHLORETHAMINE HYDROCHLORIDE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
VALCHLOR
NDA
Get alerts
MECHLORETHAMINE HYDROCHLORIDE | N202317 | HELSINN BIREX PHARMACEUTICALS LTD
1 strength
6 unique patents
0 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Price Trends
Medicare D
DMF
Approvals
Label
Products
Patent Timeline
6 unique patents by expiration date
Expired (5)
Active (1)
Today
2027
2028
2029
Today
7838564
Mar. 7, 2026
7872050
Jul. 8, 2029
8450375
Mar. 7, 2026
8501818
Mar. 7, 2026
8501819
Mar. 7, 2026
9382191
Mar. 7, 2026
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 0.016% BASE
RLD
6 patents
0 exclusivities
▴
GEL;TOPICAL | Approved: Aug 23, 2013
Patents (6)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
7838564
Mar 7, 2026
—
—
Yes
—
—
7872050
Jul 8, 2029
—
—
—
U-1427
ALKYLATING DRUG INDICATED FOR THE TOPICAL TREATMENT OF STAGE IA AND IB MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO HAVE RECEIVED PRIOR SKIN DIRECTED THERAPY
—
8450375
Mar 7, 2026
—
—
Yes
—
—
8501818
Mar 7, 2026
—
—
Yes
—
—
8501819
Mar 7, 2026
—
—
—
U-1427
ALKYLATING DRUG INDICATED FOR THE TOPICAL TREATMENT OF STAGE IA AND IB MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO HAVE RECEIVED PRIOR SKIN DIRECTED THERAPY
—
9382191
Mar 7, 2026
—
—
Yes
—
—